tirzepatide approval date GLP-1 Medications for Weight Loss: Semaglutide vs vs Retat – Revolution Health & Wellness Semaglutide & Tirzepatide: Can You

CBD suppresses caspase 1 (Yndart Arias et al

Why Brand-Name Cant Match Price Structural Barriers: Public Company Obligations: Must maximize shareholder return Quarterly earnings pressure Executive compensation tied to profits Cant dramatically reduce price without stock impact Sunk Costs: Billions invested in development Need to recoup investment Justify to shareholders and board Complex Distribution System: PBMs demand rebates Wholesalers take cut Pharmacy margins Cant easily change system Market Dynamics: Limited competition (patent protection) Can charge premium prices Demand exceeds supply No pressure to reduce Eli Lilly unlikely to reduce tirzepatide prices significantly while patents protected

Moreira, S

PMID: 36992977